Top asthma drugs in the United States based on revenue in 2011-2012 (in million U.S. dollars)

 Revenue in million U.S. dollars
Singulair 4,940.6
Advair Diskus 4,559.6
Spiriva Handihaler 2,588.8
Combivent 1,131.6
Symbicort 1,131.5
Proair HFA 1,035.5
Flovent HFA 975.4
Budesonide 923.2
Ventolin HFA 655.6
Xolair 591
Additional Information
Sign Up for Free Basic Account
Source:
Sign Up for Free Basic Account
Reading support

This statistic represents the top asthma drugs in the United States, based on revenue between July 2011 and June 2012. In this period, the asthma drug Singulair generated around 4.9 billion U.S. dollars of revenues.

You may also be interested in...
Show more
Recent Statistics
Show more
Related Reports
Health & Pharmaceuticals - Statistics & Facts
Health & Pharmaceuticals  - Statistics & Facts